- Corporate Officers - D
- Davis Todd C
Insider Trading History of Davis Todd C
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Davis Todd C since 2011.
This trader's CIK number is 1392029.
At the time of last reporting, Davis Todd C was the Chief Executive Officer of Ligand Pharmaceuticals Inc. (stock ticker symbol LGND).
Also see all insider trading activities at Ligand Pharmaceuticals Inc.
Note that in the past
Davis Todd C also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biodelivery Sciences International Inc (BDSI) by Davis Todd C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | BDSI | 0 | $0 | 0 | $0 | 7,684 | $0 |
| 2021 | BDSI | 0 | $0 | 0 | $0 | 30,000 | $0 |
| 2020 | BDSI | 0 | $0 | 50,000 | $249,500 | 30,000 | $0 |
| 2019 | BDSI | 0 | $0 | 200,000 | $1,222,000 | 18,123 | $0 |
| 2018 | BDSI | 0 | $0 | 0 | $0 | 3,124 | $0 |
Yearly summary of insider trading at Ligand Pharmaceuticals Inc (LGND) by Davis Todd C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | LGND | 9,510 | $997,827 | 0 | $0 | 0 | $0 |
| 2024 | LGND | 2,500 | $243,480 | 0 | $0 | 16,015 | $993,490 |
| 2023 | LGND | 4,000 | $237,528 | 0 | $0 | 0 | $0 |
| 2021 | LGND | 0 | $0 | 5,083 | $1,083,410 | 4,930 | $763,437 |
| 2019 | LGND | 1,000 | $93,594 | 0 | $0 | 0 | $0 |
| 2018 | LGND | 0 | $0 | 28,670 | $5,409,224 | 5,083 | $531,300 |
| 2016 | LGND | 0 | $0 | 0 | $0 | 13,980 | $713,776 |
| 2015 | LGND | 0 | $0 | 0 | $0 | 19,670 | $241,508 |
| 2014 | LGND | 0 | $0 | 7,500 | $596,782 | 0 | $0 |
| 2011 | LGND | 15,000 | $163,500 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Vaxart, Inc. (VXRT) by Davis Todd C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | VXRT | 0 | $0 | 60,000 | $196,500 | 0 | $0 |
Insider trading activities at 3 companies by Davis Todd C:
1. Biodelivery Sciences International Inc (BDSI)
2. Ligand Pharmaceuticals Inc (LGND)
3. Vaxart, Inc. (VXRT)
Table 1. Insider trading of Biodelivery Sciences International Inc (BDSI) by Davis Todd C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-27 | BDSI | Option Ex | 7,684 | .00 | 0 |
| 2021-08-06 | BDSI | Option Ex | 30,000 | .00 | 0 |
| 2020-08-18 | BDSI | Sale | 50,000 | 4.99 | 249,500 |
| 2020-08-07 | BDSI | Option Ex | 30,000 | .00 | 0 |
| 2019-11-15 | BDSI | Sale | 200,000 | 6.11 | 1,222,000 |
| 2019-08-13 | BDSI | Option Ex | 18,123 | .00 | 0 |
| 2018-08-14 | BDSI | Option Ex | 3,124 | .00 | 0 |
Table 2. Insider trading of Ligand Pharmaceuticals Inc (LGND) by Davis Todd C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-09 | LGND | Buy | 9,510 | 104.92 | 997,827 |
| 2024-08-08 | LGND | Buy | 2,500 | 97.39 | 243,480 |
| 2024-03-25 | LGND | Option Ex | 16,015 | 62.03 | 993,490 |
| 2023-09-22 | LGND | Buy | 4,000 | 59.38 | 237,528 |
| 2021-02-10 | LGND | Sale | 5,083 | 213.14 | 1,083,410 |
| 2021-02-11 | LGND | Option Ex | 2,474 | 195.91 | 484,681 |
| 2021-01-27 | LGND | Option Ex | 2,456 | 113.50 | 278,756 |
| 2019-08-02 | LGND | Buy | 1,000 | 93.59 | 93,594 |
| 2018-10-12 | LGND | Option Ex | 5,083 | 104.53 | 531,300 |
| 2018-10-08 | LGND | Sale | 2,500 | 253.99 | 634,977 |
| 2018-08-17 | LGND | Sale | 3,167 | 239.50 | 758,496 |
| 2018-08-16 | LGND | Sale | 5,833 | 239.93 | 1,399,505 |
| 2018-02-27 | LGND | Sale | 12,335 | 151.90 | 1,873,711 |
| 2018-02-26 | LGND | Sale | 4,835 | 153.57 | 742,535 |
| 2016-10-31 | LGND | Option Ex | 13,980 | 51.06 | 713,776 |
| 2015-08-06 | LGND | Option Ex | 19,670 | 12.28 | 241,508 |
| 2014-03-18 | LGND | Sale | 2,500 | 79.45 | 198,637 |
| 2014-03-19 | LGND | Sale | 5,000 | 79.63 | 398,145 |
| 2011-08-10 | LGND | Buy | 15,000 | 10.90 | 163,500 |
Table 3. Insider trading of Vaxart, Inc. (VXRT) by Davis Todd C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-04-28 | VXRT | Sale | 60,000 | 3.27 | 196,500 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Davis Todd C
(Chief Executive Officer of Ligand Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.